THE INVENTION RELATES TO A COMPOSITION THAT INCLUDES A FIRST AGENT SELECTED FROM THE GROUP CONSISTING OF AN OXIDATIVE PHOSPHORYLATION INHIBITOR, AN IONOPHORE, AND AN ADENOSINE 5'-MONOPHOSPHATE-ACTIVATED PROTEIN KINASE (AMPK) ACTIVATOR; A SECOND AGENT THAT POSSESSES ANTI-INFLAMMATORY ACTIVITY; AND A THIRD AGENT THAT POSSESSES SEROTONIN ACTIVITY.